La chaîne d'options affiche les données clés des options sur actions de Zahav à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Zahav..

Zahav (OTC:ZAHA) Stock, Chaîne d'Options

Zahav Inc

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) launched a new whiskey expression under its acclaimed <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44945150/breckenridge-distillery-announces-re-release-of-award-winning-cognac-cask-finish-whiskey" rel="noreferrer noopener">Breckenridge Distillery</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44945150/breckenridge-distillery-announces-re-release-of-award-winning-cognac-cask-finish-whiskey" rel="noreferrer noopener"> brand on Wednesday</a>.
The distillery unveiled the latest addition to its cask-finished lineup: Breckenridge Cognac Cask Finish Whiskey, which is available in Colorado with broader U.S. distribution anticipated later this year.
Originally released in 2022 as part of the second Collectors Art Series, this limited edition whiskey has returned with an elevated production run.
The label design honors its French barrel origins, featuring the iris—the national flower of France—and grape blossoms to acknowledge the Cognac region's heritage.
Bryan Nolt, founder and CEO of Breckenridge Distillery, emphasized the product's role in the company's innovation journey: "Our Cognac Cask Finish is a testament to our dedication to innovation and quality."
The new release will retail for $59.99.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44952395/us-business-activity-growth-slows-in-april-as-services-suffer-tariff-shock-markets-rally-as-trade-war-cools" rel="noreferrer noopener">Business Growth Cools, Prices Rise, And Markets Surge On Tariff Rollback Hopes</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 75% in the past year. Investors can gain exposure to the stock via&nbsp;AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Earlier in April, the company announced plans to<a target="_blank" href="https://www.benzinga.com/news/25/04/44876284/tilray-stock-hit-a-new-52-week-low-today-whats-going-on" rel="noreferrer noopener">&nbsp;implement a reverse stock split.</a>
The move, subject to shareholder approval at a June 10 special meeting, proposes a split ratio between 1-for-10 and 1-for-20. This corporate action is aimed at boosting the per-share price and maintaining compliance with Nasdaq&#8217;s minimum listing requirements.
CEO&nbsp;Irwin Simon&nbsp;said the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44859783/tilray-brands-announces-proposed-reverse-stock-split-and-corresponding-special-meeting-of-stockhol" rel="noreferrer noopener">reverse split</a>&nbsp;will better align Tilray&#8217;s share count with peers and help stabilize trading. While the fundamentals remain intact, reverse splits are often perceived negatively by investors, as they can signal financial struggles or weak stock performance.
Price Action: TLRY shares are trading lower by 2.12% to %0.4482&nbsp;at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44948932/goldman-sachs-backs-copper-tariff-trade-if-trump-slaps-25-duty-on-us-imports" target="_blank" rel="noreferrer noopener">Goldman Sachs Backs ‘Copper Tariff Trade' If Trump Slaps 25% Duty On US Imports</a></li>
</ul>
Photo: Shutterstock

Cannabis

Equities

News

Markets

Movers

General

TLRY

YOLO

What's Going On With Tilray Brands Stock Today?

WASHINGTON, April 23, 2025 /PRNewswire/ --&nbsp;Vanda Pharmaceuticals Inc. ("Vanda") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNDA#NASDAQ">VNDA</a>) today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the approvability of tradipitant for gastroparesis. Rather than take accountability, FDA bureaucrats identify a new scapegoat: newly appointed Commissioner, Dr. Martin Makary, and reductions in force.
FDA last night represented to a federal court that the April 1 reduction in force is partially to blame for the Center for Drug and Evaluation and Research's delay of at least 6 more months to provide its recommendation on whether&nbsp;the Commissioner should hold a hearing. But this cannot be true. Commissioner Makary said that any cuts were not to scientists or reviewers, the very individuals who supposedly need more time. This excuse is also suspect because CDER, in prior matters, has requested the same or longer delay to provide hearing recommendations: CDER took six months to submit a proposed order on the Hetlioz jet lag hearing request and likewise requested six months for the Hetlioz insomnia application.
It is unfair for CDER and its lawyers to blame the recent reductions in force for their habitual institutional delays on hearing requests. These statements also conceal the extraordinary fact that FDA has denied every hearing request on new drug approvability for at least the past decade.
FDA bureaucrats have created policies to avoid scrutiny of their decision-making by habitually denying hearings. FDA's office of chief counsel and DOJ have repeatedly defended FDA's right to act unlawfully when confronted by federal judges. When considering FDA's delay in resolving Vanda's hearing request in a prior instance, a federal judge pointedly asked FDA whether it was "conceding that the [HHS] Secretary is presently not complying with the statute," and a DOJ lawyer replied, "Yes, your Honor".
We urge Commissioner Makary to step in and restore adherence to the law at FDA; targeted RIFs are not to blame for FDA's culture of delay and closemindedness. Commissioner Makary and Secretary Kennedy have been clear that "radical transparency and common sense" should be the operating culture of the Agency. We also urge Attorney General Bondi to stop DOJ lawyers from defending unlawful Agency actions.
"Vanda has fought for 'transparency and common sense' for years because rational innovation can only thrive in a democracy and not in a bureaucracy. It is time for FDA and DOJ to stop fighting innovators like Vanda, focus on what is broken and listen to ideas of how it can be fixed, and usher in a new era of rational and transparent decision making," said Dr. Mihael Polymeropoulos, Vanda's President, CEO and Chairman of the Board.

VNDA

Vanda Pharma Says FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and Reductions In Force At FDA

Rezolute, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) on Wednesday announced the Independent Data Monitoring Committee&#8217;s (DMC) recommendation to continue the Phase 3 sunRIZE study as planned in patients with congenital hyperinsulinism (HI) without increasing <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44946314/rezolute-announces-positive-recommendation-after-independent-interim-analysis-of-phase-3-sunrize-s" rel="noreferrer noopener">the study sample size</a>.
HI is&nbsp;a genetic disorder in which the insulin cells of the pancreas, called beta cells, <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">secrete too much insulin</a>.
&#8220;We are thrilled with the DMC&#8217;s favorable recommendation, which appears to validate our initial assumptions for the design and powering of the Phase 3 sunRIZE study,&#8221; Rezolute Chief Medical Officer Brian Roberts said. &#8220;While we remain blinded to the partial study data and are not privy to any of the statistical outputs from the DMC, we are nevertheless encouraged by this recommendation considering past outcomes from the Phase 2 RIZE study with the same objectively measured glycemic primary endpoint, real-world observations from our Expanded Access Program, and previously announced pharmacokinetic data from the open-label arm of the sunRIZE study.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40775411/fda-gives-green-signal-to-rezolutes-genetic-disorder-treatment" rel="noreferrer noopener">FDA Gives Green Signal To Rezolute&#8217;s Genetic Disorder Treatment</a>
The company says it is on track to complete enrollment in May, with topline results anticipated in December 2025.
An unblinded DMC performed the interim analysis of the Phase 3 sunRIZE study. It was based on a pre-specified analysis of the primary study endpoint (hypoglycemia events) after approximately half of the enrolled patients completed the primary assessments.
The analysis was intended to evaluate for study futility or otherwise to inform a potential sample size increase, optimizing the study power and statistical confidence in the final analysis outcomes.
On Wednesday, Rezolute priced an underwritten offering of 20.8 million at $3.25 per share and pre-funded warrants to purchase up to 6.91 million at $3.2490 per pre-funded warrant, with approximately <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44946599/rezolute-announces-pricing-of-offering-of-90-million-of-common-stock-and-pre-funded-warrants" rel="noreferrer noopener">$90 million gross proceeds</a>.
Rezolute will use the net proceeds from the offering for research and development, general corporate expenses, and working capital needs.
Price Action: RZLT stock is up 25.7% at $3.91 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44957248/baker-hughes-posts-mixed-q1-warns-of-200m-ebitda-risk-from-tariffs-in-2025" target="_blank" rel="noreferrer noopener">Texas-Based Baker Hughes Warns Of $100-$200 Million EBITDA Risk From Tariffs In 2025</a></li>
</ul>

Biotech

Health Care

Financing

Offerings

Trading Ideas

RZLT

Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December

<a href="https://www.bloomberg.com/news/articles/2025-04-23/google-chrome-worth-upwards-of-50-billion-browser-rival-says" title="https://www.bloomberg.com/news/articles/2025-04-23/google-chrome-worth-upwards-of-50-billion-browser-rival-says">https://www.bloomberg.com/news/articles/2025-04-23/google-chrome-worth-upwards-of-50-billion-browser-rival-says</a>

GOOG

GOOGL

Bloomberg: DuckDuckGo CEO Says Google Chrome Could Be Sold For As Much As $50B

Summit Therapeutics Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) partner, Akeso, Inc., released topline data from the <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">Phase 3 HARMONi-6/K112-306 trial</a> on Wednesday.
The trial is evaluating ivonescimab in combination with platinum-based chemotherapy compared with tislelizumab, an anti-PD-1 antibody, in combination with platinum-based chemotherapy in patients with locally advanced or metastatic squamous non-small cell lung cancer (NSCLC), <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44944372/ivonescimab-in-combination-with-chemotherapy-achieves-statistically-significant-superiority-in-pfs" rel="noreferrer noopener">irrespective of PD-L1 expression</a>.
HARMONi-6 is a study conducted in China sponsored by Akeso with all relevant data exclusively generated, managed, and analyzed by Akeso.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44463128/analyst-initiates-coverage-on-undervalued-summit-therapeutics" rel="noreferrer noopener">Analyst Initiates Coverage On ‘Undervalued' Summit Therapeutics</a>
The trial met its primary endpoint of progression-free survival (PFS).
At a prespecified interim analysis conducted by an Independent Data Monitoring Committee, ivonescimab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in PFS compared to BeiGene, Ltd's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) Tevimbra (tislelizumab) plus chemotherapy.
The PFS benefit was demonstrated in patients with either PD-L1-positive or PD-L1-negative tumors.
Akeso noted that this Phase 3 study identified no new safety signals.
The full data set for HARMONi-6 will be presented at an upcoming major medical conference later this year.
The companies add that before HARMONi-6, there were no known Phase 3 trials in NSCLC that showed a statistically significant improvement compared to PD-(L)1 inhibitor therapy in combination with chemotherapy in a head-to-head setting.
Summit is currently enrolling patients in the HARMONi-3 Phase 3 study sponsored by Summit to evaluate ivonescimab combined with chemotherapy compared to Merck &amp; Co Inc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) Keytruda (pembrolizumab) combined with chemotherapy in patients with first-line metastatic, squamous and non-squamous NSCLC.
In September 2024, Summit Therapeutics&nbsp;released data from the primary analysis of the Phase 3 HARMONi-2 trial of ivonescimab <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41724651/summit-therapeutics-unique-investment-in-oncology-lead-drug-candidate-shows-promise" rel="noreferrer noopener">conducted in China</a>.
Ivonescimab monotherapy demonstrated a statistically significant improvement in the trial's primary endpoint, progression-free survival, compared to monotherapy pembrolizumab, achieving a&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40771038/summit-therapeutics-lung-cancer-candidate-surpasses-mercks-multi-billion-dollar-keytruda-cuts-ris" rel="noreferrer noopener">hazard ratio (HR) of 0.51</a>.
In February, Summit Therapeutics announced a clinical trial collaboration with Pfizer Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)&nbsp;to evaluate ivonescimab with several of Pfizer's antibody-drug conjugates (ADCs) across <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43907587/summit-therapeutics-announces-clinical-trial-collaboration-with-pfizer-to-evaluate-ivonescimab-in-" rel="noreferrer noopener">multiple solid tumor settings</a>.
Under the terms of the agreement, Summit will provide ivonescimab for use in the proposed studies, and Pfizer will be responsible for conducting the studies' operations. Summit and Pfizer will oversee the studies. Both parties retain their respective rights to their products. The studies combining ivonescimab with Pfizer's vedotin ADCs are planned to begin in the middle of this year.
Price Action: SMMT stock is up 21.11% at $33.11 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/04/44952308/boston-scientific-raises-annual-outlook-after-strong-heart-devices-sales-in-q1-announces-cfo-transition" target="_blank" rel="noreferrer noopener">Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition</a></li>
</ul>
Photo by Piotr Swat via Shutterstock

Large Cap

SMMT

Why Is Summit Therapeutics Stock Soaring On Wednesday?

The involvement of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk in politics may have hurt demand for the company's vehicles, leading to lower <a href="https://www.benzinga.com/25/04/44937440/tesla-q1-earnings-highlights-revenue-miss-eps-miss-tariff-landscape-and-changing-political-sentiment-cloud-guidance">first-quarter financial results.</a>
A group protesting against Musk says their efforts are working.
What Happened: Since February, there have been over 2,000 <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">Tesla Takedown protests</a> globally, with local organizers hosting more than 150 events each week to raise awareness about what Musk is doing in the Trump Administration and to pressure him to leave the government.
<a href="https://www.teslatakedown.com/">Tesla Takedown</a> said the electric vehicle company's financial results show that protests are working. This comes with Tesla's quarterly revenue and earnings per share missing analyst estimates.
"Today's earnings report sends a very clear message: the Tesla Takedown grassroots pressure is beginning to hit Tesla where it hurts – the company's bottom line," Tesla Takedown said via email.
The email also highlighted that Tesla's net income was down 71% year-over-year and that Tesla was on the verge of losing money without regulatory credit sales. It also hits on "promises mad. Promises broken" by Musk and Tesla, listing several items that were announced and have been delayed or never come to fruition.
"Given Elon's proven track record of broken Tesla promises, why would anyone welcome a partially sentient robot like Optimus into their home and around their family?"
The organizers behind Tesla Takedown said their cause isn't just a moment, "it's a movement."
"As Tesla stock craters and company faces dire headwinds, Musk is failing on everything except undermining our government and first amendment rights."
Tesla Takedown said Musk "launched an unprecedented assault" on public services and the rule of law.
"When people rise up, corporations pay attention. As long as Elon Musk continues to lead a regime that exploits our data, undermines public institutions, and fuels environmental destruction, the backlash against Tesla will only grow."
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44957724/tesla-stock-faces-demand-political-tariff-pressure-why-analysts-focus-on-multiple-generational-growth-drivers">Tesla Stock Faces Demand, Political, Tariff Pressure: Why Analysts Focus On &#8216;Multiple Generational Growth Drivers&#8217;</a>
 Why It's Important: Tesla Takedown said their efforts will continue. The organization said it may begin protesting other Musk-related companies in the future.
"Tesla Takedown has already started laying the groundwork to expand Tesla Takedown efforts to target other Musk businesses including SpaceX, Starlink, X and xAI." 
The organization said it would like to see governments and public pensions join the movement and stop buying Tesla vehicles and signing contracts with his companies.
Tesla Takedown encourages people to have peaceful protests against Elon Musk and Donald Trump. Musk <a href="https://www.benzinga.com/25/04/44942774/elon-musk-slams-tesla-protesters-says-they-benefited-from-government-waste-and-fraud-he-believes-to-have-cut-via-doge-theyre-the-recipients-of-wasteful-largesse">spoke out about </a>the protestors during Tesla's first-quarter earnings call, accusing the protest groups of being funded by government waste and fraud.
"They're…obviously not going to say admit that the reason that they're protesting is because they're receiving fraudulent money or that they're the recipient of wasteful largesse," Musk said.
On Tuesday, Musk said he would commit less time to the White House and more time to Tesla, beginning in May.
TSLA Price Action: Tesla stock is up 7.7% to $256.26 on Wednesday, compared to a 52-week trading range of $157.40 to $488.54. Tesla stock is down 32.5% year-to-date in 2025.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/management/25/04/44940011/benzinga-readers-predictions-for-tesla-q1-earnings-results-musks-announcements">Benzinga Readers&#8217; Predictions For Tesla Q1 Earnings Results, Musk&#8217;s Announcements</a></li>
</ul>
Photo: Shutterstock

Earnings

TSLA

Tesla Takedown Says Protests Are Working: Hitting Where It Hurts, 'The Company's Bottom Line'

Major cryptocurrencies are surging across the board as trade war tensions ease, following President Trump's remarks that talks with China are "doing fine.&#8221;
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$93,169.06</td>
<td>+1.8%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$1,779.94</td>
<td>+4.7%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$149.30</td>
<td>+3.1%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.20</td>
<td>+2.4%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1783</td>
<td>+3.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001351</td>
<td>+2.6%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 34.2% and daily active addresses growing by 17.4%. Transactions greater than $100,000 are up from 8,839 to 11,674 in a single day. Exchanges netflows are down by 122.5%.</li>
<li>Coinglass data reports 195,922 traders were liquidated in the past 24 hours for $634.49 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44957349/bitcoin-spot-etfs-record-936-million-net-inflow-ethereum-etfs-add-38-74-million">Bitcoin Spot ETFs Record $936 Million Net Inflow, Ethereum ETFs Add $38.74 Million</a></li>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44940871/elon-musk-led-tesla-reports-125-million-in-unrealized-losses-on-bitcoin-after-top-crypto-drops-12-in-q1">Elon Musk-Led Tesla Reports $125 Million In Unrealized Losses On Bitcoin After Top Crypto Drops 12% In Q1</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44942475/jack-dorsey-says-major-changes-coming-to-blocks-self-custody-bitcoin-wallet-what-to-expect">Jack Dorsey Says Major Changes Coming To Block&#8217;s Self-Custody Bitcoin Wallet: What To Expect</a></li>
<li><a href="Brandon%20Lutnick,%20Tether,%20SoftBank%20Back%20$3%20Billion%20Bitcoin%20Venture">Brandon Lutnick, Tether, SoftBank Back $3 Billion Bitcoin Venture</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/44959619/exclusive-defi-development-adds-9-9-million-in-solana-tokens-underscoring-its-commitment-towards-digital-asset-treasury-strategy">EXCLUSIVE: DeFi Development Adds $9.9 Million In Solana Tokens Underscoring Its Commitment Towards Digital Asset Treasury Strategy</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>OFFICIAL TRUMP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>)</td>
<td>$13.07</td>
<td>+46.6%</td>
</tr>
<tr>
<td>Onyxcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">XCN</a>)</td>
<td>$0.02203</td>
<td>+22.9%</td>
</tr>
<tr>
<td>Sui (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SUI</a>)</td>
<td>$2.95</td>
<td>+20.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Sistine Research has <a href="https://x.com/sistineresearch/status/1915068663310229616">set</a> a Bitcoin target at $370,000, citing a historical pattern: once BTC clears major psychological resistance zones, it tends to accelerate rapidly in momentum-fueled rallies. 
Price action is often slow and cautious at resistance, until it isn't.
ShardiB2 highlighted that Bitcoin is undergoing an orderly pullback, and a dip to the $90,000 level, marked by the green line which would still be considered structurally healthy. 
That zone could offer a high-conviction entry for bulls.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> orderly pullback.. could even go to 90k where that green line is and still be good&#8230; would be a nice entry <a href="https://t.co/mKq5BlSNkD">pic.twitter.com/mKq5BlSNkD</a>
&mdash; Don&#39;t follow Shardi B if you hate Money (@ShardiB2) <a href="https://twitter.com/ShardiB2/status/1915065870293860412?ref_src=twsrc%5Etfw">April 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Byzantine General <a href="https://x.com/ByzGeneral/status/1915060803088339259">added</a> that while Bitcoin has broken cleanly out of its downtrend, a significant technical win, this area is also a prime zone for mean reversion, with a potential move back toward the midrange before resuming trend.
Crypto trader CJ <a href="https://x.com/CJ900X/status/1914996482844840087">noted</a> Bitcoin's strong close above range highs with no short signals in sight, confirming bullish momentum. However, with price now tapping into monthly liquidity, a retracement may be imminent.
He's watching for a "three drives" pattern into $95,000. If that level triggers a reversal, it could open up a short opportunity targeting the $90,000 imbalance or the equilibrium of the previous expansion candle. 
If no reversal emerges, the bull trend remains intact, and there's no need to force trades.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44959287/bitcoin-has-likely-bottomed-at-74500-200000-is-on-the-table-says-arthur-hayes">Bitcoin Has Likely Bottomed At $74,500, $200,000 Is On The Table, Says Arthur Hayes</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$SUI

$TRUMP

$XCN

$XRP

Bitcoin, Ethereum, XRP, Dogecoin See Thundering Surge — Trader Eyes $90,000 BTC As 'Nice Entry'

<a href="https://www.benzinga.com/topic/data-center" target="_blank" rel="noreferrer noopener">Datacenter remains one</a> of few bright spots in first-quarter semiconductor earnings (i.e. Taiwan Semiconductor Manufacturing Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsm#NYSE">TSM</a>) EPS), with four major U.S. hyperscalers (Alphabet Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)) set to report in the coming weeks.
Ahead of earnings, BofA Securities analyst Vivek Arya&#8217;s consensus tracker indicates that first-quarter global hyper-scale capex will be $93.8 billion, up 71% year-over-year. For calendar years 2025 and 2026, capex is projected at $402 billion and $429 billion, approximately 4% and 7% higher than the prior outlook.
Importantly, Arya highlighted increasing concerns that AI data center buildouts might peak in 2025 and then considerably slow down afterward.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44934100/analyst-sticks-with-nvidia-despite-fallout-from-china-curbs" rel="noreferrer noopener">Analyst Sticks With Nvidia Despite Fallout From China Curbs</a>
However, he highlighted that capex from non-CSPs, including emerging cloud vendors, enterprises, and national AI infrastructure projects, could be an additional source of sustaining AI investments, filling more than any demand gap.
Overall, Arya continues to view the demand for AI computing as healthy, and the ongoing shift toward compute-hungry test-time computing and reasoning models should further help.
The analyst&#8217;s <a target="_blank" href="https://www.benzinga.com/quote/NVDA/analyst-ratings" rel="noreferrer noopener">top AI picks remain</a> Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), respective merchant and <a target="_blank" href="https://www.benzinga.com/quote/AVGO/analyst-ratings" rel="noreferrer noopener">custom AI silicon leaders</a>.
According to Arya, the reports about Microsoft canceling new data center leases and Amazon pausing certain discussions on leases are notable. The analyst explained that Microsoft's actions may be tied to OpenAI strengthening its connections with other cloud providers, while Amazon's moves could be linked to forthcoming AI Diffusion rules and may align with their broader onshoring strategies.
Meanwhile, Meta and Google recently reaffirmed their 2025 capex guides. Overall, Arya noted that AI demand is simply shifting between vendors rather than disappearing.
Price Actions: NVDA stock is up 3.4% at $102.25 at the last check on Wednesday. AVGO is up 3.8% at $176.15.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44932684/coreweaves-first-mover-advantage-and-gpu-expertise-drive-strong-growth-analysts-say" target="_blank" rel="noreferrer noopener">CoreWeave Garners Praise Due To AI Growth, Nvidia Partnership</a></li>
</ul>
Photo: Shutterstock

Analyst Ratings

Tech

AMZN

AVGO

MSFT

NVDA

Nvidia, Broadcom Chosen As Top Semiconductor Picks For AI Leadership By Analyst

Chinese internet companies, including ByteDance, Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), and Tencent Holding (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>), hoarded billions of dollars worth of Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) H20 <a target="_blank" href="https://www.benzinga.com/topic/ai" rel="noreferrer noopener">artificial intelligence (AI) chips</a> as the U.S. semiconductor sanctions kicked in.
Nvidia tailor-made the H20 chips to comply with U.S. semiconductor sanctions. However, the Chinese companies started hoarding them in 2024, fearing potential shipment restrictions, Nikkei Asia <a target="_blank" href="https://asia.nikkei.com/Business/Tech/Semiconductors/ByteDance-Alibaba-and-Tencent-stockpile-billions-worth-of-Nvidia-chips" rel="noreferrer noopener">reported</a> on Wednesday.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44897214/nvidia-discusses-ai-powering-future-with-japan-amid-rising-energy-demands" rel="noreferrer noopener">Nvidia&#8217;s Jensen Huang Meets Japanese PM To Discuss AI&#8217;s Growing Energy Needs</a>
They aimed to snap up 1 million H20s before the latest U.S. semiconductor sanctions. The companies <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44846329/nvidias-china-sales-face-setback-as-h20-chip-restrictions-catch-key-buyers-off-guard-reuters" rel="noreferrer noopener">reportedly placed over</a> $16 billion in orders for the quarter.&nbsp;
According to the report, Nvidia bagged $18 billion of H20 orders since 2025 beginning.
China generated $17 billion in revenue in fiscal 2024, accounting for 13% of Nvidia&#8217;s total sales.
In March, Alibaba Chairman Joe Tsai <a href="https://www.benzinga.com/media/25/03/44274410/alibaba-chair-says-ai-total-addressable-market-is-10-trillion-expects-benefits-via-its-cloud-business" target="_blank" rel="noreferrer noopener">told CNBC that</a> AI&#8217;s total addressable market is at least $10 trillion. Alibaba was among the first major global tech companies to open-source its large-scale AI models. Over the next three years, Alibaba earmarked $53 billion for cloud and AI infrastructure.
Alibaba, also known as China&#8217;s tech barometer, surged over 36% year-to-date, fueled by optimism over additional domestic government stimulus and the popularity of Chinese AI startup DeepSeek&#8217;s promises of affordable AI models topping OpenAI and peers.
Dan Ives&nbsp;of Wedbush Securities called Alibaba the &#8220;best way to play China tech,&#8221; citing its strong positioning in AI and cloud.
Following the H20 effective shipment ban to China on April 15,&nbsp;Nvidia stock has declined 14%, versus the PHLX Semiconductor Sector&#8217;s 8% and the S&amp;P 500&#8217;s 4%.
BofA Securities analyst Vivek Arya&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44934100/analyst-sticks-with-nvidia-despite-fallout-from-china-curbs" rel="noreferrer noopener">noted China and</a> H20 exposure as generally de-risked and expected Nvidia&#8217;s gross margins to typically improve throughout the fiscal second half as Blackwell gains scale and Blackwell Ultra ramps up.
Although the upcoming AI Diffusion Rule remains Nvidia&#8217;s most significant near-term risk, Arya&nbsp;reiterated a Buy rating on&nbsp;Nvidia, citing the current stock volatility as an enhanced buying opportunity.
Price Actions: NVDA stock is up 3.34% at $102.19 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/44935325/why-are-us-listed-chinese-stocks-trading-higher-on-tuesday" target="_blank" rel="noreferrer noopener">Alibaba, EV Stocks Jump As U.S.-China Tensions Cool — But Europe Still A Wild Card</a></li>
</ul>
Photo by Hepha1st0s via Shutterstock

Asia

Government

Regulations

Media

BABA

TCEHY

China's Big Tech Firms Hoard Nvidia AI Chips Before Latest US Sanctions

Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) has long been a hot favorite in burrito bowls <a href="https://www.benzinga.com/etfs">and ETF portfolios</a>.
However, with analysts tempering their expectations and the stock losing 18.3% year to date, ETFs that were once feasting on Chipotle might now be excusing themselves from the table.
<h2 class="wp-block-heading">Who&#8217;s Got Chipotle on the Menu?</h2>
Several standout ETFs include Chipotle in their holdings—either for its growth story, brand power, or margins. Here&#8217;s who&#8217;s likely mulling the latest news:
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/44947467/voo-vs-vti-buffett-approves-this-battle-for-your-portfolio">VOO Vs. VTI: Buffett Approves This Battle For Your Portfolio</a>
<ul>
<li>Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>): A juggernaut ETF of large consumer favorites, XLY has had Chipotle as one of its growth bets, alongside Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and McDonald&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>). But CMG&#8217;s recent softness could count against its spice factor overall. Currently, the fund has cut it&#8217;s <a href="https://www.ssga.com/us/en/intermediary/etfs/the-consumer-discretionary-select-sector-spdr-fund-xly">exposure </a>to the stock to 1.9% of its overall AUM.</li>
</ul>
<ul>
<li>iShares U.S. Consumer Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYC#NYSE">IYC</a>): The fund provides general <a href="https://www.ishares.com/us/products/239506/ishares-us-consumer-discretionary-etf">exposure </a>to consumer services, where Chipotle&#8217;s high-end dining experience has gotten it included. Price target cuts by analysts may prompt fund managers to reconsider their holding, which has already gone down to 1.2%.</li>
</ul>
<ul>
<li>AdvisorShares Restaurant ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EATZ#NYSE">EATZ</a>): Arguably the most burrito-invested fund on Wall Street, EATZ has a stake in both fast-casual and full-service restaurants. With Chipotle&#8217;s stock now plummeting, the ETF will take the burn harder, as Chipotle <a href="https://advisorshares.com/etfs/eatz/#holdings">enjoys </a>more than 3% of the fund&#8217;s AUM.</li>
</ul>
Though these funds aren&#8217;t ditching Chipotle quite yet, they&#8217;re definitely serving up the risk salsa as analysts call for more restraint ahead of earnings.
<h2 class="wp-block-heading">What&#8217;s Cooking?</h2>
When Chipotle announces earnings on Wednesday, <a href="https://www.benzinga.com/general/restaurants/25/04/44952286/chipotle-international-expansion-on-the-menu-analyst-cautions-on-guidance-tariffs-in-earnings-preview">it&#8217;ll be offering up more than just revenue and EPS</a>—it&#8217;ll be serving up macro trends, international strategy, and how it&#8217;s coping with tariffs and cost pressures.
Guggenheim&#8217;s Gregory Francfort recently cut his price target from $56 to $48, citing weak traffic, weather issues, and lukewarm credit card data. While keeping his rating at Neutral, he anticipates a same-store sales downgrade to &#8220;flat to low single digits.&#8221;
Also Read: <a href="https://www.benzinga.com/general/restaurants/25/04/44823749/wall-street-sours-on-chipotle-here-are-etfs-caught-in-the-crossfire">Wall Street Sours On Chipotle: Here Are ETFs Caught In The Crossfire</a>
And Francfort&#8217;s not the only one. Other analysts are joining in. Barclays cut the price target from $60 to $56; Truist came down to $61 from $74; Wells Fargo is down to $60 from $70; UBS has gone from $70 to $65; and KeyBanc, from $64 to $60.
But some numbers provide a counterpoint. Placer.ai <a href="https://www.placer.ai/anchor/articles/mcdonalds-chipotle-in-the-new-year-q1-recap">tracks </a>Q1 traffic expansion of 4.5% YoY, significantly beating the fast-casual category&#8217;s 4.2% decline. Chipotle&#8217;s new Honey Chicken introduction can potentially drive comps too.
<h2 class="wp-block-heading">A Global Game Plan</h2>
Chipotle just revealed plans to move into Mexico in 2026 through a deal with restaurant behemoth Alsea. That would be the chain&#8217;s seventh global market. With more than 3,700 restaurants today and a 7,000-store long-term target in North America, global expansion is the new frontier, but it could be a hard sell in a rough macroeconomic climate.
At the same time, management is absorbing<a href="https://www.benzinga.com/topic/tariffs"> tariff-driven cost increases</a> (avocados, we're looking at you), which might win over avocado loyalists but could hurt margins in upcoming guidance.
<h2 class="wp-block-heading">Is Chipotle Still ETF-Worthy?</h2>
While Chipotle is still a high-growth competitor with strong brand power, investors, ETF managers, and analysts like Francfort are wondering if the premium multiple is still warranted. A solid earnings report might revive optimism, but anything short of that might lead ETFs to begin cutting exposure.
Ultimately, Chipotle&#8217;s next earnings plate will indicate if it&#8217;s still a market delicacy… or merely extra guac on a dwindling budget.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44934617/the-magnificent-meltdown-qqq-tanks-as-big-techs-shine-wears-off-but-theres-a-silver-lining">Magnificent Meltdown: QQQ Tanks As Big Tech&#8217;s Shine Wears Off, But There&#8217;s A Silver Lining</a></li>
</ul>
Image: Shutterstock

Specialty ETFs

ETFs

EATZ

iShares Trust Dow Jones USnsumer Services Sector Index Fund

Select Sector SPDR-Consumer Discretionary

Chipotle Isn't So Hot Ahead Of Earnings: Will ETFs Push The Plate Away?

NIO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) stock is moving higher after President Donald Trump indicated that the final tariff rate with China would be &#8220;substantially&#8221; below the current 145% <a href="https://www.benzinga.com/government/regulations/25/04/44959325/stocks-surge-on-china-tariff-hopes-tesla-jumps-gold-loses-shine-whats-driving-markets-wednesday">but not 0%.</a>
The Details: According to the <a href="https://www.wsj.com/politics/policy/white-house-considers-slashing-china-tariffs-to-de-escalate-trade-war-6f875d69?mod=hp_lead_pos1">Wall Street Journal</a>, a senior White House official said that the Trump administration is contemplating lowering the rate to between 65% and 50%. The administration may also adopt a tiered approach, with tariff rates varying based on what is deemed strategic to America's interests.
Trump said he was optimistic about trade talks and plans to be "very nice" in order to reach a deal. The move is part of the administration&#8217;s attempt to ease tensions in the US–China trade relationship.
China has signaled it is open to trade talks with the US, but not under threats from the administration.
No final decision has been made regarding the tariff rate with China.
NIO and several other US-listed Chinese stocks may be moving higher as lower tariffs on raw materials and components could ease production costs. NIO has also expressed strong interest in entering the U.S. market, where high tariffs would present a barrier to competitive pricing.
The automobile industry and NIO may also be getting a boost after Tesla reported first-quarter earnings Tuesday after the market closed. During <a href="https://www.benzinga.com/25/04/44940401/elon-musk-says-hell-only-spend-day-or-two-per-week-on-government-matters-to-ensure-fraud-does-not-come-roaring-back-ceos-focus-to-shift-to-tesla-beginning-may">the earnings call</a>, CEO Elon Musk told investors he is reducing his time commitment to the Department of Government Efficiency.
Investors may see Musk's reduced government focus as a signal that he plans to dedicate more time to Tesla's core operations, which could boost confidence in the broader EV sector, including companies like NIO.
Related Link: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44961386/pepe-surges-23-in-7-days-can-it-flip-shiba-inu-dogecoin">Pepe Surges 23% In 7 Days: Can It Flip Shiba Inu, Dogecoin?</a>
NIO Price Action: At the time of publication, NIO stock is trading 5.20% higher at $3.94, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: via Shutterstock

NIO Stock Trades Higher On Potential China Tariff Cuts, EV Sector Optimism

Tariffs have created plenty of economic uncertainty, but inflation numbers have actually been good so far. According to the U.S. Bureau of Labor Statistics, the consumer price index <a href="https://www.bls.gov/news.release/cpi.nr0.htm">increased by 2.4% year-over-year in March</a>.
Steady inflation has increased speculation that the Fed will eventually cut interest rates. However, real estate investor Grant Cardone believes that big rate cuts are guaranteed. He <a href="https://x.com/GrantCardone/status/1912618410497782149">posted a chart on X</a> to strengthen his claim.
"Gold is acting like we are in a depression. Rates will drop like a rock," Cardone explained.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
The chart shows gold going from $2,000 per ounce near the end of 2023 to more than $3,300 per ounce today. It also shows that gold's price has soared ever since the trade war began.
<h2 class="wp-block-heading">Gold Is Viewed As A Safe Haven</h2>
Many investors retreat into precious metals like gold and silver when financial markets become uncertain. Tariffs have resulted in sharp price swings in the stock market, along with a weakening U.S. dollar. When the dollar gets weak, gold gains value.
The sharp rise in gold may signal that investors are fearful of the future and don't want to get caught holding equities. Gold also performed well when Trump used tariffs during his first term. For instance, the S&amp;P 500 lost more than 15% of its value from Aug. 31, 2018, to the end of 2018. Gold rallied by about 7% during the same stretch.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">The Previous Trade War Suggests Rate Cuts Will Come In A Few Months</h2>
The time between August and December 2018 is important because it relates to Trump's first-term tariffs. The Federal Reserve raised interest rates twice during those few months. A 0.25% on Sept. 27, 2018, set the stage for a 0.25% hike on Dec. 20, 2018. It was a part of the Fed's multiyear effort to raise rates after keeping them at record lows for several years.
The Fed made those rate hikes amid a trading war between the U.S. and China that started in January 2018. Now, we find ourselves in a trade war that started in February. It's more dramatic than the first one, hence gold's strong year-to-date gains.&nbsp;
Although the Fed raised rates several times in 2019, they reduced rates three times in 2019 due to the trade war. The rate cuts came in August, September, and October of that year. Each rate cut was a 0.25% drop. Although the S&amp;P 500 was battered in 2018, it delivered a return of nearly 30% in 2019.&nbsp;
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
If history repeats, the stock market may generate robust returns in 2026, but that remains to be seen. For now, Cardone believes the Fed will have to reduce rates. If inflation readings remain low, the Fed will have enough flexibility to cut rates. A big rate drop can help equities rally.&nbsp;
<h2 class="wp-block-heading">Not Everyone Thinks The Fed Will Cut Rates</h2>
Some replies under Cardone's X post were a bit skeptical. Some people believe the Fed will hike rates to keep inflation at bay. That scenario could risk stagflation, a popular talking point in 2022.&nbsp;
The Fed wasn't afraid to raise interest rates during Trump's first trade war. The same scenario can unfold again, but the Fed may end up making sharp cuts in 2026, just as they did in 2019. While three 0.25% drops may not sound like much, the Fed reduced the federal funds rate from the 2.25%-2.50% range to the 1.50%-1.75% range.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Grant Cardone Shares A Chart That Indicates The Fed Will Drop Rates: 'Gold Is Acting Like We Are In A Depression'

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) has tapped its long-term supplier, Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), for its <a target="_blank" href="https://www.benzinga.com/topic/semiconductors" rel="noreferrer noopener">advanced 2nm process</a>.
Intel and Taiwan Semiconductor are collaborating on a 2nm product to manufacture the compute tile for Intel&#8217;s next-gen Nova Lake PC processors, which are expected in 2026, TechNode <a target="_blank" href="https://technode.com/2025/04/23/intel-reportedly-places-orders-for-tsmcs-2nm-process/" rel="noreferrer noopener">reports</a>.
Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) is already a client of Taiwan Semiconductor&#8217;s 2nm process.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/asia/25/04/44932342/taiwan-semiconductors-arizona-factory-faces-441-million-loss-amid-supply-chain-labor-cost-challenges" rel="noreferrer noopener">Taiwan Semiconductor&#8217;s Arizona Factory Faces $441 Million Loss Amid Supply Chain, Labor Cost Challenges</a>
Last February, Intel CEO Pat Gelsinger confirmed that the company had, for the first time, outsourced the compute tiles of two processors to Taiwan Semiconductor, which became the Intel Core Ultra 200V laptop series (Lunar Lake) and the Core Ultra 200S desktop series (Arrow Lake), its first AI PC processors.
Recently, Taiwan Semiconductor <a href="https://www.benzinga.com/25/04/44857887/taiwan-semiconductor-q1-surges-41-in-sales-boosted-by-ai-chip-demand-expanded-margins" target="_blank" rel="noreferrer noopener">told Bloomberg that</a> it did not engage in discussions to form a venture or share its technology with any company, dismissing speculation of possible collaboration with Intel. 
The Taiwan Semiconductor and Intel collaboration reports gained traction after Taiwan Semiconductor announced an additional $100 billion investment in U.S. chipmaking (on top of $65 billion in April 2024). 
Intel chief Lip-Bu Tan will likely meet Taiwanese suppliers in May to celebrate the inauguration of the Computex Taipei trade show, the Taipei Times <a target="_blank" href="https://www.taipeitimes.com/News/biz/archives/2025/04/23/2003835641" rel="noreferrer noopener">reported</a>, citing supply chain sources on Monday. Tan is attempting to turn around the struggling US chipmaker.
Tan will hold a banquet to celebrate Intel&#8217;s 40-year presence in Taiwan before Computex opens on May 20 and invite Taiwanese suppliers to discuss global semiconductor industry dynamics. Tan would visit Intel suppliers in Taiwan.
In Intel&#8217;s latest annual report, Tan discussed prioritizing its position in the cloud-based artificial intelligence data center market and creating advanced process technologies to build its wafer foundry business.
Price Actions: INTC stock is up by 5.25% to $20.54 at the last check on Wednesday. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44934176/rivian-taps-ai-expert-aidan-gomez-to-drive-innovation-advanced-technology-integration" target="_blank" rel="noreferrer noopener">Tesla Rival Rivian Taps AI Expert Aidan Gomez To Drive Innovation</a></li>
</ul>
Photo Courtesy: Tada Images On Shutterstock

INTC

Intel Taps Taiwan Semiconductor For Advanced 2nm Process For AI-Powered Chips: Report

Shares of technology company Coupang Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) are <a href="https://www.benzinga.com/movers">trading higher on Wednesday</a> after launching a new program aimed at allowing American businesses to pitch and sell products internationally.
Partnering with the International Trade Administration, the initiative <a href="https://www.benzinga.com/pressreleases/25/04/b44948143/coupang-partners-with-the-department-of-commerces-international-trade-administration-to-help-ameri">aims to boost U.S. exports</a> and create new global sales opportunities.
Called Rocket Pitch, the program offers U.S. businesses a chance to present their consumer products during an online event held in collaboration with the U.S. Commercial Service. 
The program will spotlight major product sectors such as food and drinks, dietary supplements, infant care, fitness nutrition, and personal care items.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/04/44949808/zyn-gum-makers-smoke-free-business-revenue-jumps-15-raises-annual-profit-outlook">Zyn Gum Maker&#8217;s Smoke-Free Business Revenue Jumps 15%, Raises Annual Profit Outlook</a>
Companies chosen will get instant purchase commitments from Coupang, South Korea's leading e-commerce platform. Coupang is aiming to facilitate the export of American-made products by removing common barriers to entry. 
Alongside automatic purchase agreements, the company will offer marketing support, translation services, logistics solutions, customs handling, and customer service management. 
&#8220;Coupang makes global expansion easy for U.S. sales partners of any size, and we have all the tools you need to be a success at cross-border trade,&#8221; said Coupang&#8217;s Vice President of Global eCommerce, Jonathan Burks.
Sellers will also benefit from return handling and guidance from U.S. trade experts.
South Korea, ranked as the world's fourth-largest e-commerce market, boasts an active online shopper base, with 98% of South Koreans aged 20-39 shopping online. 
Coupang&#8217;s logistics system promises ultra-fast delivery options, including same-day and overnight shipping, giving U.S. exporters a competitive edge.
Price Action: CPNG shares traded higher by 4.1% at $22.58 at last check Wednesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44936972/vertiv-nvidia-igenius-launch-ai-supercomputer-project-in-italy">Vertiv, NVIDIA, iGenius Launch AI Supercomputer Project In Italy</a></li>
</ul>
Photo: Shutterstock

CPNG

Coupang Teams Up With US Trade Officials To Supercharge American Exports

Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), the world's largest gold producer, saw a pullback Wednesday following favorable industry conditions and <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44933680/gold-miners-surge-50-year-to-date-as-record-bullion-prices-drive-optimism-ahead-of-earnings">record gold prices</a>.
Shares of gold stocks are trading lower as gold prices drop after President Trump said he has <a href="https://www.benzinga.com/25/04/44940900/us-futures-dollar-jump-amid-trumps-latest-comments-on-fed-nikkei-rebounds-to-three-week-high">no intention of firing</a> Fed Chair Powell and indicated the final tariff rate with China would be &#8220;substantially&#8221; lower than the current 145%. These comments could be reducing some macro uncertainty, which recently drove gold to record highs.
What To Know: Gold briefly touched $3,500 per ounce this month, driven by sticky inflation, geopolitical tensions and surging investor demand. 
With gold <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44933680/gold-miners-surge-50-year-to-date-as-record-bullion-prices-drive-optimism-ahead-of-earnings">averaging $2,862 per ounce</a> in the first-quarter 2025 and miners enjoying all-in sustaining costs near $1,400–$1,500, Newmont could report robust margins and strong free cash flow in its upcoming earnings release.
However, the stock has slipped as investor appetite shifts toward higher-growth tech names and Bitcoin, <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44958259/bitcoin-reclaims-spotlight-while-gold-loses-luster-the-safe-haven-standoff-continues">which reclaimed $94,000</a> amid renewed "digital gold" enthusiasm.
The pullback could also reflect elevated expectations of late — Newmont, having completed an acquisition of <a href="https://www.benzinga.com/news/asset-sales/24/11/42202141/newmont-sells-mine-for-795-million-barrick-expands-reserves-top-miners-unfazed-by-underperformance">Newcrest Mining in 2023</a>, is under scrutiny to deliver on promised synergies and operational efficiency.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44959325/stocks-surge-on-china-tariff-hopes-tesla-jumps-gold-loses-shine-whats-driving-markets-wednesday">Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What&#8217;s Driving Markets Wednesday?</a>
Price Action: NEM is trading lower by 2.6% to $53.11 Wednesday afternoon.
<h2 class="wp-block-heading">How To Buy NEM Stock</h2>
By now you're likely curious about how to participate in the market for Newmont &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Newmont, which is trading at $53.16 as of publishing time, $100 would buy you 1.88 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, NEM has a 52-week high of $58.72 and a 52-week low of $36.86.

Why Newmont (NEM) Shares Are Trading Lower Today

By now, anyone watching markets for more than a few months knows the truth: short-term market moves are anyone&#8217;s guess, but over the long haul, valuation is destiny.
When it comes to long-term opportunities in the market indexes, you&#8217;ve got to get under the hood of sentiment, valuation, and allocation. That&#8217;s where three time-tested signals come in: the market cap-to-GDP ratio (Buffett&#8217;s favorite valuation compass), aggregate investor allocation to equities (an under-the-radar sentiment gauge), and the excess CAPE yield (a rare bright light in the world of macro).
Together, they don&#8217;t just whisper. They shout.
Specifically, they shout that stocks are a loser's game, and that you need to invest in a very specific asset class. 
Don't worry – doing so is easy, profitable, and pays an 8.5% yield, too.
Let&#8217;s start with the most poetic signal of them all, Warren Buffett&#8217;s beloved Market Cap to GDP.
At present, the total U.S. market cap (Wilshire 5000) sits well over 170% of U.S. GDP. Historically, a ratio over 120% indicated future annual returns well below the long-term average of ~9–10%. 
At today&#8217;s stretched levels, we&#8217;re firmly in the danger zone. Past instances (think 1999) saw returns that struggled to break the mid-single digits, even before accounting for inflation.
If mean reversion is the rule (and it always eventually is), then we are looking at forward nominal returns in the neighborhood of 3–5%, possibly lower if we go full cycle and dip below the mean.
Next up, Investor Allocation to Equities, which might be the most predictive (and most ignored) signal of the three. The Federal Reserve&#8217;s Financial Accounts data tells us what share of household financial assets is in equities. Right now, that&#8217;s hovering near all-time highs at roughly 45% of assets. And here&#8217;s the rub: historically, when equity allocations are this high, future ten-year returns tend to come in very low.
A 2012 study by J.P. Morgan&#8217;s Michael Cembalest showed that the equity allocation metric was incredibly accurate when predicting subsequent ten-year returns.
At today&#8217;s levels, that model implies sub-3% real returns on the S&amp;P 500. If you&#8217;re counting on 7–8% a year to fund your retirement, you&#8217;d better hope for a miracle, or a crash that resets the starting line.
Finally, the Excess CAPE Yield, which compares the inverse of the Shiller CAPE ratio (that is, earnings yield) to the ten-year Treasury yield. It&#8217;s one of the few signals that adjusts for the low-rate environment. Currently, with a CAPE of ~33 and ten-year yields above 4.5%, the excess yield is approaching negative territory.
That&#8217;s a historically awful setup.
Whenever excess CAPE yield has turned negative, future returns tend to hover at or below the rate of inflation.
The basic logic? If you can get 4.5% with no risk and stocks are offering a real yield of less than 3%, the equity risk premium is functionally zero.
There&#8217;s simply no reason to stretch for stocks, unless you&#8217;re betting on multiple expansion from already excessive levels. Good luck with that.
Put it all together and here&#8217;s the story: the S&amp;P 500 is priced to deliver at best 3–4% nominal returns annually over the next decade, with a decent shot of dipping closer to 1–2% if we get a proper valuation washout. And that&#8217;s before factoring in inflation. On a real return basis, you could be looking at flat or even negative returns over the next ten years. That&#8217;s not a doomsday forecast.
It&#8217;s the historical norm when starting valuations and sentiment are this euphoric.
Could we do better? Sure.
Markets are not math equations, and momentum can keep valuations lofty longer than any sane person would expect.
But betting your money on that outcome is playing chicken with history.
There is an asset class and strategy that can put us on the right side of history and deliver solid returns even if stocks do better than expected: the forgotten workhorses of the capital markets.
I&#8217;m talking about the upper tier of the high-yield market, otherwise known as &#8220;fallen angels&#8221; or &#8220;almost junk.&#8221; These bonds have a fascinating habit of quietly winning when nobody&#8217;s looking.
This has been especially true during equity market &#8220;lost decades,&#8221; when the S&amp;P 500 spins its wheels and delivers little to no return for years on end. These bonds have consistently proven themselves to be a reliable, even remarkable, source of income and capital appreciation.
Let&#8217;s set the historical table. The 1970s and the 2000 to 2010 periods are the two big &#8220;lost decades&#8221; most investors remember.
During the inflation-ravaged 1970s, high-quality high-yield bonds quietly outperformed both stocks and government bonds, delivering nominal returns in the 8–10% range while equities barely kept pace with inflation.
The S&amp;P 500 returned just under 6% annually in nominal terms, but with inflation averaging over 7%, real returns were negative.
There were also massive drawdowns of 50% of so in the indexes.
By contrast, bonds offering high yields and moderate credit risk provided a steady stream of income that not only kept up with inflation but also offered positive absolute returns.
Unlike lower-rated junk bonds, these bonds avoided the worst default risk while still capturing a significant portion of the excess yield available during a decade marked by rising rates and economic instability.
From 2000 through 2009, the S&amp;P 500 had a total return of -0.9%, a negative return over ten full years, including dividends. The market had to digest the dot-com collapse, the accounting scandals, 9/11, and finally the global financial crisis. It was a brutal stretch for equity investors.
Meanwhile, high-quality high-yield bonds delivered positive annualized returns north of 7%. That&#8217;s not just a win. It&#8217;s a rout.
These bonds effectively live in the &#8220;sweet spot&#8221; of the credit spectrum: high enough yield to matter, low enough risk to survive.
Institutional investors who bought high-quality, high-yield bonds and held them to maturity were clipping generous coupons, while stock investors endured a rollercoaster that ultimately went nowhere in real terms.
While long-duration Treasuries got crushed and equities faced P/E compression, high-quality high-yield bonds quietly delivered. If we&#8217;re heading into another period of stagflation or a lost decade in stocks, history suggests these bonds could once again be the unsung heroes of portfolio construction.
My favorite way to invest in high-quality high-yield bonds is through individual bonds.
I cut my teeth on credit back in the late 1980s and early 1990s during the wreckage of the Michael Milken and corporate raider era.
Digging through financial statements to find bargains is, as Austin Powers might opine, &#8220;My bag, baby.&#8221;
However, it is a very hands-on strategy and is not always an easy market for individuals to trade.
My favorite way for most investors to play this lucrative market right now is ETF from Infrastructure Capital Advisors. The firm&#8217;s new Capital Bond Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNDS#NYSE">BNDS</a>) is high-quality high-yield done right.
Fund manager Jay Hatfield&#8216;s approach to markets and credit is similar to mine.
The portfolio is comprised of bonds that I would cheerfully add to my own.
Hatfield also opportunistically uses an option-writing strategy to enhance income while maintaining upside market exposure by using high-yield ETFs.
The current distribution yield is 8.5%, and many of the issues trade at a significant discount to par value.
If valuation and economic measures prove to be right again, the yield alone will deliver a significant premium to the return of the S&amp;P 500.
The narrowing of the discount as bonds move closer to maturity or prices move higher in response to credit upgrades or fed actions will be a bonus.
<h2 class="wp-block-heading">Gold Pullback Alert: Matt Maley's Next Trade</h2>
The same strategy that delivered a verified 2,400% gain on SQQQ for Matt's Inner Circle members is now signaling a gold trade. Get The Newest Trade Alert For Free Right <a href="https://www.benzinga.com/premium/ideas/7-day-free-trial-matt-maley-inner-circle/?el=R[…]}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0424&amp;utm_campaign=7daytrial">HERE</a>.
Editorial content from our Expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies which are neither expressly or impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Opinion

BNDS

3 Key Signals Say It's Time To Invest In This 'Forgotten' Market, Here's How

Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock is trading higher amid overall market strength after President Donald Trump said he had no intention of firing Federal Reserve Chair Jerome Powell.
The Details: According to the <a href="https://www.wsj.com/politics/elections/trump-says-he-has-no-intention-of-firing-fed-chair-powell-eda4c6a7">Wall Street Journal</a>, Trump told reporters he wants Powell to "be a little more active in terms of his idea to lower interest rates," but added, "no, I have no intention to fire him." This comes after Trump wrote on <a href="https://truthsocial.com/@realDonaldTrump/posts/114376239725335883">Truth Social</a> Monday that Powell has always been "Too Late" on interest rate decisions.
Trump made similar threats toward the Fed during his first term. In December 2018, he threatened to fire Powell as the Fed raised interest rates.
More recently, Trump told reporters he believes he has the authority to fire Powell, saying, "If I want him out, he'll be out of there real fast, believe me," though Powell has expressed a differing view on the matter.
Super Micro, along with the broader semiconductor sector, may be moving higher as Trump&#8217;s comments ease investor uncertainty around Fed leadership and fuel market optimism.
What Else: The Trump administration is also considering lowering tariffs on Chinese goods, which currently reach as high as 145%, in an effort to ease tensions in the U.S. trade relationship with China, per the <a href="https://www.wsj.com/politics/policy/white-house-considers-slashing-china-tariffs-to-de-escalate-trade-war-6f875d69">Wall Street Journal.</a>
Although no final decision has been made, a senior White House official said tariffs are likely to be reduced to between 50% and 65%. Trump stated that the final rate won&#8217;t be 0%.
The administration may also adopt a tiered approach, with tariff rates varying based on what is deemed strategic to America's interests.
This news may be lifting Super Micro, and the chip industry, as a potential tariff reduction could ease investor concerns around trade and supply chain disruptions, which has been weighing on the sector.
See Also: <a href="https://www.benzinga.com/personal-finance/25/04/44958370/1-5m-rich-but-clueless-couple-with-82k-combined-income-says-need-help-after-winning-big-reddit-explodes-over-what-they-should-do-next">$1.5M Rich But Clueless – Couple With $82K Combined Income Says &#8216;Need Help&#8217; After Winning Big, Reddit Explodes Over What They Should Do Next</a>
SMCI Price Action: At the time of publication, Super Micro shares are trading 7.39% higher at $32.84, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: This illustration was generated using artificial intelligence via Midjourney.

SMCI

Super Micro Stock Gains As Trump Signals No Plans To Fire Powell

Enphase Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) shares are falling Wednesday after the company reported worse-than-expected financial results for the first quarter. Multiple analysts also lowered price targets <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">following the print</a>.
<ul>
<li>Q1 Revenue: $356.1 million, versus<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener"> estimates</a>&nbsp;of $361.43 million</li>
</ul>
<ul>
<li>Q1 EPS: 68 cents, versus estimate of 70 cents</li>
</ul>
Enphase said U.S. revenue decreased approximately 13% quarter-over-quarter due to seasonality and "softening" U.S. demand. Revenue in Europe was up approximately 7% quarter-over-quarter, driven by higher battery sales. The solar company said it shipped approximately 1.53 microinverters, representing 170.1 megawatt hours of IQ batteries in the quarter.
Enphase Energy generated&nbsp;$48.4&nbsp;million&nbsp;in cash flow from operations and $33.8 million in free cash flow during the quarter. Enphase ended the quarter with $1.53 billion in cash, cash equivalents, restricted cash and marketable securities.
Guidance: Enphase sees second-quarter revenue in the range of $340 million to $380 million. The company guided for second-quarter gross margin of 42% to 45%, or 44% to 47% on an adjusted basis. The gross margin forecast includes approximately two percentage points of new tariff impacts.
See Also: <a href="https://www.benzinga.com/government/regulations/25/04/44959325/stocks-surge-on-china-tariff-hopes-tesla-jumps-gold-loses-shine-whats-driving-markets-wednesday">Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What&#8217;s Driving Markets Wednesday?</a>
Analyst Changes:
<ul>
<li>Susquehanna analyst Biju Perincheril maintained Enphase with a <a href="https://www.benzinga.com/analyst-stock-ratings">Neutral</a> and lowered the price target from&nbsp;$59&nbsp;to&nbsp;$51.</li>
</ul>
<ul>
<li>BMO Capital analyst Ameet Thakkar maintained Enphase with a Market Perform and lowered the price target from&nbsp;$59&nbsp;to&nbsp;$46.</li>
</ul>
<ul>
<li>Goldman Sachs analyst Brian Lee maintained Enphase with a Buy and lowered the price target from&nbsp;$90&nbsp;to&nbsp;$77.</li>
</ul>
<ul>
<li>Piper Sandler analyst Kashy Harrison maintained Enphase with a Neutral and lowered the price target from&nbsp;$47&nbsp;to&nbsp;$42.</li>
</ul>
<ul>
<li>RBC Capital analyst Christopher Dendrinos reiterated Enphase with a Sector Perform and lowered the price target from&nbsp;$59&nbsp;to&nbsp;$54.</li>
</ul>
ENPH Price Action: <a href="https://www.benzinga.com/quote/ENPH" target="_blank" rel="noreferrer noopener">Enphase Energy shares</a> were down 15.7% at $45.05 at the time of publication Wednesday, per <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. Enphase shares are now down approximately 33% year-to-date and are nearing five-year lows.
Photo: <a href="https://www.shutterstock.com/g/Alyoshin+E">AlyoshinE</a>/Shutterstock.

Price Target

ENPH

Enphase Energy Stock Is Tumbling Wednesday: Why Investors Are Selling Shares

Americans are rushing to buy cars ahead of looming price hikes, fueling a short-term spending spree on goods most vulnerable to the latest <a href="https://www.benzinga.com/news/econ-s">wave of tariff disruptions.</a>
In its Beige Book released Wednesday, the Federal Reserve said most regional districts reported moderate to robust vehicle sales, attributing the surge to "a rush to purchase ahead of tariff-related price increases." 
The data underscores growing anxiety as the 25% tariff on imported automobiles, imposed by the Trump administration, took effect on April 3.
<h3 class="wp-block-heading">A Tale of Two Consumers: Autos Hot, Everything Else Not</h3>
While Americans are racing to lock in car deals, non-auto consumer spending has taken a hit. 
The Beige Book's national summary described overall economic activity as "little changed," with only five of the 12 Fed districts reporting slight growth. In contrast, three districts were flat, and four reported declines.
The diverging consumer behavior is stark. In the Cleveland district, for instance, retail demand slumped, but auto dealers saw a wave of customers "pulling forward purchases" in anticipation of higher prices. 
In New York, economic activity contracted modestly, and businesses conveyed "significant concern about tariffs," leading many to brace for declining activity and surging costs.
<h3 class="wp-block-heading">Inflation Fears Mount As Tariff Surcharges Hit Supply Chains</h3>
Prices rose across all districts due to trade disruptions. 
At least six districts described the price growth as moderate, and another six as modest, yet across the board, tariffs were named as a key driver. Businesses are already receiving cost-hike notifications from suppliers and in many cases are adding surcharges or shortening pricing horizons.
"Most businesses expected to pass through additional costs to customers," the Fed said, although several also flagged the risk of margin compression as demand weakens, particularly for consumer-facing firms.
In Kansas City, expectations of price growth rose "at a robust rate," particularly in the goods sector, while in Dallas, "input cost pressures accelerated" and outlooks deteriorated amid trade uncertainty.
<h3 class="wp-block-heading">Outlook Worsens As Trade Uncertainty Takes Hold</h3>
The clearest theme from the Fed's April Beige Book is that the U.S. economy is barely growing. 
While pockets of strength, like the auto sales boom, show consumers are still willing to spend, those surges appear driven by fear of future costs rather than optimism.
That fear of higher prices, lower margins, and supply disruptions is increasingly shaping decisions for both consumers and businesses. 
Michigan-based automakers General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) are scheduled to release their first-quarter earnings on April 29 and May 5, respectively.
Investors will be closely watching to see whether the recent increase in vehicle sales has come with added costs—and how that has impacted automakers' profit margins.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44957724/tesla-stock-faces-demand-political-tariff-pressure-why-analysts-focus-on-multiple-generational-growth-drivers">Tesla Stock Faces Demand, Political, Tariff Pressure: Why Analysts Focus On &#8216;Multiple Generational Growth Drivers&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Macro Economic Events

Econ #s

Economics

Federal Reserve

STLA

Americans Rush To Buy Cars Ahead Of Tariff Price Hikes, Fed Beige Book Shows

Cybersecurity provider Check Point Software Technologies&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44943335/check-point-software-reports-2025-first-quarter-financial-results" rel="noreferrer noopener">fiscal first-quarter results</a> on Wednesday.
The company reported quarterly revenue growth of 7% year over year to $637.8 million, topping the&nbsp;analyst consensus estimate of $636.2 million.&nbsp;
The American Israeli enterprise security solution&nbsp;provider&#8217;s&nbsp;adjusted EPS of $2.21 beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $2.19</a>. The stock declined following the report, despite the earnings beat.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43459532/check-point-boosts-threat-prevention-with-upgraded-infinity-platform" rel="noreferrer noopener">Check Point Boosts Threat Prevention with Upgraded Infinity Platform</a>
Revenue from&nbsp;Products&nbsp;and licenses grew by 14% Y/Y to $114 million,&nbsp;Security&nbsp;subscriptions increased 10% Y/Y to $291 million, and&nbsp;Software&nbsp;updates and maintenance declined 0.9% Y/Y to $233 million.
Margin: Adjusted operating margin declined to 40.5% from 42.1% the prior year.&nbsp;The operating margin declined to 30.7% from 32.4% a year ago as operating expenses surged by 9.2% Y/Y.
The company generated $421.1 million in operating cash flow, compared to $361.0 million a year ago, and held $2.93 billion in cash and equivalents as of March 31, 2025.
CEO Nadav Zafrir said strong demand for its Quantum Force appliances, fueled by refresh cycles and new projects, delivered double-digit year-over-year product and license revenue growth. He added that the AI-driven Infinity Platform, featuring a Hybrid Mesh Architecture, continues to resonate with customers and delivered another quarter of impressive double-digit year-over-year growth.
Outlook: Check Point Software <a target="_blank" href="https://www.checkpoint.com/about-us/investor-relations/" rel="noreferrer noopener">projected second-quarter</a> revenue of $642.00 million —$682.00 million versus the analyst consensus estimate of $665.75 million and adjusted EPS of $2.32-$2.42 versus the analyst consensus estimate of $2.36.
The company affirmed fiscal 2025 revenue of $2.66 billion-$2.76 billion versus the $2.72 billion <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst consensus estimate</a> and adjusted EPS of $9.60-$10.20 versus the $9.91 analyst consensus estimate.
Price Action: CHKP stock is down 5.04% at $201.61 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44903362/american-express-solid-revenue-and-spending-trends-drive-analyst-optimism" target="_blank" rel="noreferrer noopener">American Express&#8217; Solid Revenue, Spending Trends Drive Analyst Optimism</a></li>
</ul>

Comments

Zahav

Zahav (ZAHA) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL